dc.contributor.author |
Handgretinger, Rupert |
de_DE |
dc.date.accessioned |
2014-10-08T14:20:53Z |
|
dc.date.available |
2014-10-08T14:20:53Z |
|
dc.date.issued |
2014 |
de_DE |
dc.identifier.issn |
0732-183X |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/56853 |
|
dc.language.iso |
en |
en |
dc.publisher |
Amer Soc Clinical Oncology |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1200/JCO.2013.50.4423 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140813180100_00503 |
de_DE |
utue.publikation.seiten |
1445- |
de_DE |
utue.personen.roh |
Navid, Fariba |
de_DE |
utue.personen.roh |
Sondel, Paul M. |
de_DE |
utue.personen.roh |
Barfield, Raymond |
de_DE |
utue.personen.roh |
Shulkin, Barry L. |
de_DE |
utue.personen.roh |
Kaufman, Robert A. |
de_DE |
utue.personen.roh |
Allay, Jim A. |
de_DE |
utue.personen.roh |
Gan, Jacek |
de_DE |
utue.personen.roh |
Hutson, Paul |
de_DE |
utue.personen.roh |
Seo, Songwon |
de_DE |
utue.personen.roh |
Kim, KyungMann |
de_DE |
utue.personen.roh |
Goldberg, Jacob |
de_DE |
utue.personen.roh |
Hank, Jacquelyn A. |
de_DE |
utue.personen.roh |
Billups, Catherine A. |
de_DE |
utue.personen.roh |
Wu, Jianrong |
de_DE |
utue.personen.roh |
Furman, Wayne L. |
de_DE |
utue.personen.roh |
McGregor, Lisa M. |
de_DE |
utue.personen.roh |
Otto, Mario |
de_DE |
utue.personen.roh |
Gillies, Stephen D. |
de_DE |
utue.personen.roh |
Handgretinger, Rupert |
de_DE |
utue.personen.roh |
Santana, Victor M. |
de_DE |
dcterms.isPartOf.ZSTitelID |
Journal of Clinical Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
14 |
de_DE |
dcterms.isPartOf.ZS-Volume |
32 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |